Conning Inc. decreased its position in Humana Inc. (NYSE:HUM) by 3.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,667 shares of the insurance provider’s stock after selling 126 shares during the period. Conning Inc.’s holdings in Humana were worth $882,000 as of its most recent filing with the SEC.
A number of other institutional investors have also recently made changes to their positions in HUM. ProShare Advisors LLC increased its position in shares of Humana by 15.8% in the first quarter. ProShare Advisors LLC now owns 17,297 shares of the insurance provider’s stock worth $3,566,000 after buying an additional 2,356 shares during the last quarter. Profund Advisors LLC increased its position in shares of Humana by 14.6% in the first quarter. Profund Advisors LLC now owns 6,131 shares of the insurance provider’s stock worth $1,264,000 after buying an additional 782 shares during the last quarter. Korea Investment CORP increased its position in shares of Humana by 38.3% in the first quarter. Korea Investment CORP now owns 65,815 shares of the insurance provider’s stock worth $13,567,000 after buying an additional 18,239 shares during the last quarter. Mn Services Vermogensbeheer B.V. increased its position in shares of Humana by 4.1% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 3,976 shares of the insurance provider’s stock worth $766,000 after buying an additional 158 shares during the last quarter. Finally, Nationwide Fund Advisors increased its position in shares of Humana by 41.1% in the first quarter. Nationwide Fund Advisors now owns 210,027 shares of the insurance provider’s stock worth $43,295,000 after buying an additional 61,185 shares during the last quarter. Institutional investors own 99.13% of the company’s stock.
Shares of Humana Inc. (HUM) opened at 246.83 on Wednesday. The company has a 50-day moving average of $240.31 and a 200-day moving average of $223.89. The firm has a market capitalization of $35.67 billion, a PE ratio of 20.31 and a beta of 0.91. Humana Inc. has a 52 week low of $163.50 and a 52 week high of $255.27.
Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, topping the consensus estimate of $3.08 by $0.41. Humana had a net margin of 3.37% and a return on equity of 15.85%. The firm had revenue of $13.53 billion for the quarter, compared to analysts’ expectations of $13.61 billion. During the same period in the previous year, the business earned $2.30 earnings per share. On average, equities analysts forecast that Humana Inc. will post $11.55 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: “Conning Inc. Has $882,000 Stake in Humana Inc. (HUM)” was published by Community Financial News and is the property of of Community Financial News. If you are accessing this report on another domain, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The correct version of this report can be read at https://www.com-unik.info/2017/08/16/conning-inc-has-882000-stake-in-humana-inc-hum.html.
A number of brokerages have commented on HUM. UBS AG restated a “neutral” rating and set a $250.00 price objective (up previously from $237.00) on shares of Humana in a research report on Wednesday, August 9th. BidaskClub upgraded shares of Humana from a “sell” rating to a “hold” rating in a research report on Thursday, August 10th. Cantor Fitzgerald restated a “neutral” rating and set a $223.00 price objective (up previously from $200.00) on shares of Humana in a research report on Thursday, August 3rd. Jefferies Group LLC restated a “hold” rating and set a $257.00 price objective on shares of Humana in a research report on Friday, August 4th. Finally, Deutsche Bank AG upped their price objective on shares of Humana from $234.00 to $243.00 and gave the stock a “hold” rating in a research report on Monday, August 7th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have issued a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $243.65.
In other Humana news, VP Heidi S. Margulis sold 1,500 shares of the business’s stock in a transaction dated Friday, May 26th. The shares were sold at an average price of $231.96, for a total value of $347,940.00. Following the sale, the vice president now directly owns 8,150 shares in the company, valued at $1,890,474. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Brian P. Leclaire sold 4,971 shares of the business’s stock in a transaction dated Wednesday, June 28th. The stock was sold at an average price of $240.00, for a total transaction of $1,193,040.00. Following the completion of the sale, the senior vice president now owns 14,258 shares in the company, valued at $3,421,920. The disclosure for this sale can be found here. Over the last quarter, insiders sold 41,406 shares of company stock worth $10,355,086. 0.80% of the stock is owned by company insiders.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
What are top analysts saying about Humana Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Humana Inc. and related companies.